TGFBR1 Gene

Last updated on: 14.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The TGFBR1 gene (TGFBR1 stands for "Transforming Growth Factor Beta Receptor 1") is a protein coding gene located on chromosome 9q22.33. Several transcript variants encoding different isoforms have been found for this gene.

The protein encoded by this gene, Activin Receptor-Like Kinase 5, is a serine/threonine protein kinase characterized by transfer of phosphorus-containing groups. It forms, after binding to TGF-beta, a heteromeric complex with type II TGF-beta receptors. This transmits the TGF-beta signal from the cell surface to the cytoplasm.

This regulates a variety of physiological and pathological processes, including cell cycle arrest in epithelial and hematopoietic cells, control of proliferation and differentiation of mesenchymal cells, wound healing, extracellular matrix production, immunosuppression, and carcinogenesis.

Clinical pictureThis section has been translated automatically.

Diseases associated with TGFBR1 include:

Associated pathways include the NF-kappaB pathway and cytokine production by Th17 cells. People with Loeys-Dietz syndrome often develop immunological disorders: food allergies, asthma or signs of atopic dermatitis or inflammatory bowel disease. There are overlaps with the hyper-IgE syndrome.

LiteratureThis section has been translated automatically.

  1. Biskind GR. Et al. (1957) Multiple primary self-healing squamous-cell epitheliomas of the skin: generalized keratoacanthoma. AMA Arch Derm 75: 210-223.
  2. BoseS et al. (2006) The elusive multiple self-healing squamous epithelioma (MSSE) gene: further mapping, analysis of candidates, and loss of heterozygosity. Oncogene 25: 806-812.
  3. Currie AR et al (1952) Multiple primary spontaneous-healing squamous-cell carcinomata of the skin. J Path Bact 64: 827-839.
  4. Degos R et al (1964) Spontaneous-healing epitheliomas Ferguson-Smith and multiple familial keratoacanthomas. Dermatologist 15: 7-11.
  5. Ferguson Smith JA (1934) A case of multiple primary squamous-celled carcinomata of the skin in a young man, with spontaneous healing. Brit J Derm 46: 267-272.
  6. Ferguson-Smith MA et al (1971) Multiple self-healing squamous epithelioma. Birth Defects Orig Art Ser VII(8): 157-163.
  7. Goudie DR et al (1991) Localization of the gene for multiple self-healing squamous epithelioma (Ferguson-Smith type) to the long arm of chromosome 9. (Abstract) Cytogenet Cell Genet 58: 1939.
  8. Goudie, D. R., Yuille, M. A. R., Leversha, M. A., Furlong, R. A., Carter, N. P., Lush, M. J., Affara, N. A., Ferguson-Smith, M. A. Multiple self-healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nature Genet. 3: 165-169, 1993. [PubMed: 8499949, related citations] [Full Text].
  9. Richards FM et al (1997) Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and patched (PTCH) as candidate genes. Hum Genet 101: 317-322.
  10. Sommerville J et al (1950) Familial primary self-healing squamous epithelioma of the skin. Brit J Derm Syph 62: 485-490.

Last updated on: 14.04.2022